Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Gatipotuzumab |
| Synonyms | |
| Therapy Description |
Gatipotuzumab is a humanized monoclonal antibody targeting tumor-associated MUC1, which potentially induces antibody-dependent cellular cytotoxicity (ADCC) and tumor cell death (PMID: 16485130). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Gatipotuzumab | pankomab|pankoMab-GEX | MUC1 Antibody 8 | Gatipotuzumab is a humanized monoclonal antibody targeting tumor-associated MUC1, which potentially induces antibody-dependent cellular cytotoxicity (ADCC) and tumor cell death (PMID: 16485130). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|